You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

May 8, 2020

Atthachai Homhuan Leads Webinar on Thailand’s Medical Device Regulatory Response to COVID-19

On May 8, 2020, Atthachai Homhuan, manager, regulatory affairs, at Tilleke & Gibbins, was the invited speaker for a Licensing Executives Society (LES) Thailand webinar about the COVID-19 responses of the Thai Food and Drug Administration (FDA) and the Department of International Trade (DIT). He spoke about the ongoing steps the Thai FDA and DIT have taken to encourage the domestic availability of critical products for the fight against COVID-19.

Within the Thai FDA, the Medical Device Control Division has introduced expedited pathways to speed the registration of tools and equipment necessary for preventing the spread of the virus. The DIT’s involvement has centered around the guidance issued by the Central Committee on Prices of Goods and Services, which has put in place export controls to prevent medical device shortages in Thailand due to exports of equipment such as domestically produced masks.

This members-only webinar was held as part of LES Thailand’s efforts to share timely information on intellectual property commercialization, licensing activities, and business-related regulatory affairs. LES Thailand brings together entrepreneurs, legal and professional service providers, and many others with common interests in technology licensing and IP. For more information, please visit the LES Thailand website.

RELATED INSIGHTS​ 

May 29, 2012
The ASEAN Economic Community (AEC), which will come into effect in 2015, will integrate the region’s economies and create a single market of 600 million consumers. All industries are bracing for this change, but the competitive landscape is transforming even more quickly in the healthcare sector. Regional harmonization has already commenced for the cosmetics industry, while further integration is imminent for other industries and products, such as medical devices.
May 29, 2012
The Thai pharmaceutical industry is characterized by its expanding yet challenging landscape. Amidst growing medical tourism and strong R&D centers in the Asia Pacific region, issues related to patent protection, counterfeit drugs, and innovation recognition are increasingly imperative for pharmaceutical companies.
April 26, 2012
Three members of the Tilleke & Gibbins team have been named to The International Who’s Who of Life Sciences Lawyers 2012. Published by Law Business Research, the official research partner of the International Bar Association, this guide identifies 546 experts in 48 jurisdictions who are considered leaders in serving clients in the life sciences sector.The Tilleke & Gibbins attorneys recognized by the publication are: